XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Class A and Class B Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2019   22,173,216 12,193,677      
Beginning balance at Dec. 31, 2019 $ 87,679 $ 107,953 $ 0 $ 2,288 $ (22,586) $ 24
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     40,207      
Issuance of Class A common stock from exercise of options 24     24    
Vesting of early exercised stock options and restricted common stock 4     4    
Stock-based compensation 579     579    
Other comprehensive loss 533         533
Net loss (5,493)       (5,493)  
Ending balance (in shares) at Mar. 31, 2020   22,173,216 12,233,884      
Ending balance at Mar. 31, 2020 83,326 $ 107,953 $ 0 2,895 (28,079) 557
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     11,877      
Issuance of Class A common stock from exercise of options 28     28    
Repurchase of Class A common stock (in shares)     (215,245)      
Repurchase of Class A common stock 0          
Vesting of early exercised stock options and restricted common stock 10     10    
Issuance of stock (in shares)   6,853,571        
Issuance of stock 54,896 $ 54,896        
Stock-based compensation 808     808    
Other comprehensive loss (255)         (255)
Net loss (6,117)       (6,117)  
Ending balance (in shares) at Jun. 30, 2020   29,026,787 12,030,516      
Ending balance at Jun. 30, 2020 132,696 $ 162,849 $ 0 3,741 (34,196) 302
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     611,824      
Issuance of Class A common stock from exercise of options 42     42    
Vesting of early exercised stock options and restricted common stock 49     49    
Distribution of PrognomIQ shares (40)     (40)    
Stock-based compensation 1,177     1,177    
Other comprehensive loss (159)         (159)
Net loss (8,229)       (8,229)  
Ending balance (in shares) at Sep. 30, 2020   29,026,787 12,642,340      
Ending balance at Sep. 30, 2020 $ 125,536 $ 162,849 $ 0 4,969 (42,425) 143
Beginning balance (in shares) at Dec. 31, 2020 59,261,051 0 59,261,051      
Beginning balance at Dec. 31, 2020 $ 431,609 $ 0 $ 1 486,915 (55,361) 54
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     399,174      
Issuance of Class A common stock from exercise of options 171     171    
Repurchase of Class A common stock (in shares)     (876)      
Vesting of early exercised stock options and restricted common stock 44     44    
Issuance of stock (in shares)     1,650,000      
Issuance of stock 102,959     102,959    
Return of profit 11,403     11,403    
Stock-based compensation 6,039     6,039    
Other comprehensive loss (26)         (26)
Net loss (16,429)       (16,429)  
Ending balance (in shares) at Mar. 31, 2021   0 61,309,349      
Ending balance at Mar. 31, 2021 $ 535,770 $ 0 $ 1 607,531 (71,790) 28
Beginning balance (in shares) at Dec. 31, 2020 59,261,051 0 59,261,051      
Beginning balance at Dec. 31, 2020 $ 431,609 $ 0 $ 1 486,915 (55,361) 54
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares) 760,383          
Ending balance (in shares) at Sep. 30, 2021 61,653,898 0 61,653,898      
Ending balance at Sep. 30, 2021 $ 515,196 $ 0 $ 1 621,994 (106,791) (8)
Beginning balance (in shares) at Mar. 31, 2021   0 61,309,349      
Beginning balance at Mar. 31, 2021 535,770 $ 0 $ 1 607,531 (71,790) 28
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     132,766      
Issuance of Class A common stock from exercise of options 236     236    
Repurchase of Class A common stock (in shares)     (18,852)      
Vesting of early exercised stock options and restricted common stock 285     285    
Stock-based compensation 6,431     6,431    
Other comprehensive loss (62)         (62)
Net loss (16,616)       (16,616)  
Ending balance (in shares) at Jun. 30, 2021   0 61,423,263      
Ending balance at Jun. 30, 2021 526,044 $ 0 $ 1 614,483 (88,406) (34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class A common stock from exercise of options (in shares)     230,635      
Issuance of Class A common stock from exercise of options 631     631    
Vesting of early exercised stock options and restricted common stock 94     94    
Stock-based compensation 6,786     6,786    
Other comprehensive loss 26         26
Net loss $ (18,385)       (18,385)  
Ending balance (in shares) at Sep. 30, 2021 61,653,898 0 61,653,898      
Ending balance at Sep. 30, 2021 $ 515,196 $ 0 $ 1 $ 621,994 $ (106,791) $ (8)